Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126396181 | 12639618 | 1 | I | 20160808 | 20160810 | 20160810 | EXP | IN-ROCHE-1810560 | ROCHE | RAMASWAMY A, OSTWAL V, PANDE N, SAHU A, JANDYAL S, RAMADWAR M, SHETTY N, PATKAR S, GOEL M AND GUPTA S SECOND-LINE PALLIATIVE CHEMOTHERAPY IN ADVANCED GALL BLADDER CANCER, CAP-IRI: SAFE AND EFFECTIVE OPTION. JOURNAL OF GASTROINTESTINAL CANCER 2016;47(3):305-312. | 0.00 | Y | 0.00000 | 20160810 | OT | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126396181 | 12639618 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | ||||||||||
| 126396181 | 12639618 | 2 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 | ||||||||||
| 126396181 | 12639618 | 3 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 126396181 | 12639618 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 126396181 | 12639618 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126396181 | 12639618 | 6 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 0 | |||||||||||
| 126396181 | 12639618 | 7 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | 0 | |||||||||||
| 126396181 | 12639618 | 8 | SS | CETUXIMAB | CETUXIMAB | 1 | Unknown | 0 | |||||||||||
| 126396181 | 12639618 | 9 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126396181 | 12639618 | 1 | Gallbladder cancer |
| 126396181 | 12639618 | 2 | Gallbladder cancer |
| 126396181 | 12639618 | 3 | Gallbladder cancer |
| 126396181 | 12639618 | 4 | Gallbladder cancer |
| 126396181 | 12639618 | 5 | Gallbladder cancer |
| 126396181 | 12639618 | 6 | Gallbladder cancer |
| 126396181 | 12639618 | 7 | Gallbladder cancer |
| 126396181 | 12639618 | 8 | Gallbladder cancer |
| 126396181 | 12639618 | 9 | Gallbladder cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126396181 | 12639618 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126396181 | 12639618 | Diarrhoea | |
| 126396181 | 12639618 | Febrile neutropenia | |
| 126396181 | 12639618 | Hyperbilirubinaemia | |
| 126396181 | 12639618 | Infection | |
| 126396181 | 12639618 | Mucosal inflammation | |
| 126396181 | 12639618 | Neutropenia | |
| 126396181 | 12639618 | Palmar-plantar erythrodysaesthesia syndrome | |
| 126396181 | 12639618 | Thrombocytopenia | |
| 126396181 | 12639618 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |